Low-dose methadone has an analgesic effect in neuropathic pain: a double-blind randomized controlled crossover trial

Abstract

The analgesic effectiveness and adverse effect incidence of a daily dose of 10 or 20 mg of oral methadone were evaluated in 18 patients with a diverse range of chronic neuropathic pain syndromes, who had all responded poorly to traditional analgesic regimens. Analgesia was seen after each dose of methadone. As compared with placebo, the 20 mg daily dose (given as 10 mg bd) resulted in statistically significant (P = 0.013-0.020) improvements in patient Visual Analogue Scale ratings of maximum pain intensity, average pain intensity and pain relief, recorded at the same time daily. The analgesic effects extended over 48 hours, as shown by statistically significant (P = 0.013-0.020) improvements in all three outcomes on the rest days instituted between each daily dose. Analgesic effects (lowered maximum pain intensity and increased pain relief, on the day of dosing only) were also seen when the lower daily dose of 10 mg methadone (given as 5 mg bd) was used, but these failed to reach statistical significance (P = 0.064 and 0.065, respectively). Interpatient analysis showed that the analgesic effects were not restricted to any particular type of neuropathic pain. Patient compliance was high throughout the trial. One patient withdrew during the 10 mg and six during the 20 mg methadone treatment periods. This is the first double-blind randomized controlled trial to demonstrate that methadone has an analgesic effect in neuropathic pain.

Effects of testosterone on lean mass gain in elderly men: systematic review with meta-analysis of controlled and randomized studies

“…However, the effects of these types of treatment are not fully understood, since their objectives, dosages and duration as well as the association with physical activity adds complexity to the data provided by the studies on this theme (Kenny et al 2000;Morley et al 2003;Snyder et al 1999;Tenover 1998).…”

The impact of medication regimen factors on adherence to chronic treatment: a review of literature

“…The authors posit that adherence would be enhanced due to the fewer doses required, but do not provide evidence of this relationship. Morley et al (2003) conducted a double-blind study of 10 vs. 20 mg methadone to determine its efficacy as a treatment for chronic neuropathic pain. They reported "high compliance", but adherence was not measured or described in a standardized manner (Morley et al 2003).…”

“…Morley et al (2003) conducted a double-blind study of 10 vs. 20 mg methadone to determine its efficacy as a treatment for chronic neuropathic pain. They reported "high compliance", but adherence was not measured or described in a standardized manner (Morley et al 2003). In an older study, Kubacka and Juhl (1985) explored attitudes about medication dosing among patients with chronic pain or hypertension.…”

Cancer-related pain management in clinical oncology

“…Given its various mechanisms of action, methadone can be efective in multifaceted pain syndromes involving both somatic and neuropathic pain, although there are conficting results in neuropathic pain studies. 47,48 Given methadone's variable and long half-life, clinicians should be watchful for adverse events as a result of drug accumulation. 49 Methadone's pharmacokinetics can be especially variable in cancer patients because methadone binds avidly to alpha1-glycoproteins, the levels of which are increased in cancer patients, which can lead to a decrease in unbound methadone and a delayed onset of efect.…”